United Therapeutics (UTHR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
UTHR dips 1.5% to $533.12. Closed at $533.12, -1.55% vs the prior close of $541.51. Day range $530.18–$551.77, opened at $545.49.
UTHR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — UTHR dips 1.5% to $533.12
- Closed at $533.12, -1.55% vs the prior close of $541.51. Day range $530.18–$551.77, opened at $545.49.
- Volume was 654.28K shares, 0.9x its 50-day average of 764.17K.
- Price is +3.6% vs its 50-day average ($514.66) and +1.2% vs its 200-day average ($527.00).
- 52-week range $409.07–$609.35; today's close sits at 62% of that range, 12.5% below the 52-week high.
Oct 15, 2026 — UTHR ends flat (+0.3%) to $541.51
- Closed at $541.51, +0.27% vs the prior close of $540.03. Day range $538.07–$551.83, opened at $545.24.
- Volume was 532.40K shares, 0.7x its 50-day average of 768.12K.
- Price is +5.2% vs its 50-day average ($514.66) and +2.8% vs its 200-day average ($526.82).
- 52-week range $409.07–$609.35; today's close sits at 66% of that range, 11.1% below the 52-week high.
Oct 14, 2026 — UTHR dips 0.6% to $540.03
- Closed at $540.03, -0.62% vs the prior close of $543.40. Day range $523.95–$546.89, opened at $543.18.
- Volume was 883.20K shares, 1.2x its 50-day average of 760.89K.
- Price is +5.0% vs its 50-day average ($514.21) and +2.5% vs its 200-day average ($526.63).
- 52-week range $409.07–$609.35; today's close sits at 65% of that range, 11.4% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 — UTHR dips 1.2% to $543.40
- Closed at $543.40, -1.22% vs the prior close of $550.10. Day range $542.23–$553.99, opened at $551.59.
- Volume was 537.70K shares, 0.7x its 50-day average of 758.69K.
- Price is +5.8% vs its 50-day average ($513.78) and +3.2% vs its 200-day average ($526.46).
- 52-week range $409.07–$609.35; today's close sits at 67% of that range, 10.8% below the 52-week high.
Oct 12, 2026 — UTHR ends flat (+0.2%) to $550.10
- Closed at $550.10, +0.17% vs the prior close of $549.16. Day range $547.76–$555.59, opened at $553.49.
- Volume was 840.60K shares, 1.1x its 50-day average of 754.21K.
- Price is +7.2% vs its 50-day average ($513.24) and +4.5% vs its 200-day average ($526.32).
- 52-week range $409.07–$609.35; today's close sits at 70% of that range, 9.7% below the 52-week high.
Oct 9, 2026 — UTHR jumps 3.1% to $549.16
- Closed at $549.16, +3.07% vs the prior close of $532.78. Day range $528.92–$551.15, opened at $528.92.
- Volume was 577.90K shares, 0.8x its 50-day average of 752.10K.
- Price is +7.1% vs its 50-day average ($512.59) and +4.4% vs its 200-day average ($526.12).
- 52-week range $409.07–$609.35; today's close sits at 70% of that range, 9.9% below the 52-week high.
Oct 8, 2026 — UTHR dips 2.2% to $532.78 on 2.0x normal volume
- Closed at $532.78, -2.24% vs the prior close of $545.00. Day range $524.79–$545.00, opened at $545.00.
- Volume was 1.44M shares, 2.0x its 50-day average of 734.61K — unusually heavy trading.
- Price is +4.0% vs its 50-day average ($512.13) and +1.3% vs its 200-day average ($525.94).
- 52-week range $409.07–$609.35; today's close sits at 62% of that range, 12.6% below the 52-week high.
Oct 7, 2026 — UTHR rises 0.6% to $545.00
- Closed at $545.00, +0.62% vs the prior close of $541.62. Day range $541.90–$558.30, opened at $542.41.
- Volume was 1.01M shares, 1.4x its 50-day average of 723.43K.
- Price is +6.5% vs its 50-day average ($511.97) and +3.6% vs its 200-day average ($525.86).
- 52-week range $409.07–$609.35; today's close sits at 68% of that range, 10.6% below the 52-week high.
Oct 6, 2026 — UTHR rises 1.0% to $541.62
- Closed at $541.62, +0.97% vs the prior close of $536.40. Day range $527.33–$546.16, opened at $537.19.
- Volume was 1.21M shares, 1.7x its 50-day average of 707.79K.
- Price is +5.9% vs its 50-day average ($511.54) and +3.0% vs its 200-day average ($525.67).
- 52-week range $409.07–$609.35; today's close sits at 66% of that range, 11.1% below the 52-week high.
Oct 5, 2026 — UTHR dips 1.0% to $536.40
- Closed at $536.40, -0.98% vs the prior close of $541.70. Day range $535.53–$547.98, opened at $540.41.
- Volume was 833.70K shares, 1.2x its 50-day average of 697.38K.
- Price is +4.9% vs its 50-day average ($511.26) and +2.1% vs its 200-day average ($525.52).
- 52-week range $409.07–$609.35; today's close sits at 64% of that range, 12.0% below the 52-week high.
Oct 2, 2026 — UTHR slides 5.2% to $541.70
- Closed at $541.70, -5.19% vs the prior close of $571.38. Day range $541.27–$577.02, opened at $570.00.
- Volume was 1.12M shares, 1.6x its 50-day average of 679.84K.
- Price is +6.0% vs its 50-day average ($511.11) and +3.1% vs its 200-day average ($525.34).
- 52-week range $409.07–$609.35; today's close sits at 66% of that range, 11.1% below the 52-week high.
UTHR latest news & SEC filings
Every SEC filing by or about UTHR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rothblatt Martine A converted options/RSUs into 9,500 shares at $117.76 (≈$1.12M) on Oct 15, 2026; now holds 333,943
- Rothblatt Martine A sold 281 shares at $540.48 (≈$151.87K) on Oct 15, 2026; now holds 333,662
- Rothblatt Martine A sold 1,163 shares at $541.59 (≈$629.86K) on Oct 15, 2026; now holds 332,499
- Rothblatt Martine A sold 456 shares at $542.68 (≈$247.46K) on Oct 15, 2026; now holds 332,043
- Rothblatt Martine A sold 371 shares at $543.39 (≈$201.60K) on Oct 15, 2026; now holds 331,672
- Rothblatt Martine A sold 269 shares at $544.75 (≈$146.54K) on Oct 15, 2026; now holds 331,403
- …plus 7 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mahon Paul A converted options/RSUs into 8,300 shares at $146.03 (≈$1.21M) on Oct 15, 2026; now holds 53,472
- Mahon Paul A sold 268 shares at $541.64 (≈$145.16K) on Oct 15, 2026; now holds 53,204
- Mahon Paul A sold 1,924 shares at $542.49 (≈$1.04M) on Oct 15, 2026; now holds 51,280
- Mahon Paul A sold 1,983 shares at $543.56 (≈$1.08M) on Oct 15, 2026; now holds 49,297
- Mahon Paul A sold 791 shares at $544.85 (≈$430.98K) on Oct 15, 2026; now holds 48,506
- Mahon Paul A sold 2,615 shares at $545.69 (≈$1.43M) on Oct 15, 2026; now holds 45,891
- …plus 1 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rothblatt Martine A converted options/RSUs into 9,500 shares at $117.76 (≈$1.12M) on Oct 14, 2026; now holds 333,943
- Rothblatt Martine A sold 40 shares at $526.07 (≈$21.04K) on Oct 14, 2026; now holds 333,903
- Rothblatt Martine A sold 160 shares at $530.09 (≈$84.81K) on Oct 14, 2026; now holds 333,743
- Rothblatt Martine A sold 120 shares at $531.19 (≈$63.74K) on Oct 14, 2026; now holds 333,623
- Rothblatt Martine A sold 40 shares at $532.48 (≈$21.30K) on Oct 14, 2026; now holds 333,583
- Rothblatt Martine A sold 240 shares at $534.63 (≈$128.31K) on Oct 14, 2026; now holds 333,343
- …plus 11 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 15, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rothblatt Martine A converted options/RSUs into 9,500 shares at $117.76 (≈$1.12M) on Oct 13, 2026; now holds 333,943
- Rothblatt Martine A sold 639 shares at $542.76 (≈$346.82K) on Oct 13, 2026; now holds 333,304
- Rothblatt Martine A sold 2,340 shares at $543.48 (≈$1.27M) on Oct 13, 2026; now holds 330,964
- Rothblatt Martine A sold 1,492 shares at $544.56 (≈$812.48K) on Oct 13, 2026; now holds 329,472
- Rothblatt Martine A sold 1,507 shares at $545.52 (≈$822.10K) on Oct 13, 2026; now holds 327,965
- Rothblatt Martine A sold 1,452 shares at $546.46 (≈$793.46K) on Oct 13, 2026; now holds 326,513
- …plus 5 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rothblatt Martine A converted options/RSUs into 9,500 shares at $117.76 (≈$1.12M) on Oct 12, 2026; now holds 333,943
- Rothblatt Martine A sold 428 shares at $548.13 (≈$234.60K) on Oct 12, 2026; now holds 333,515
- Rothblatt Martine A sold 1,329 shares at $549.01 (≈$729.64K) on Oct 12, 2026; now holds 332,186
- Rothblatt Martine A sold 2,565 shares at $550.03 (≈$1.41M) on Oct 12, 2026; now holds 329,621
- Rothblatt Martine A sold 2,628 shares at $551.10 (≈$1.45M) on Oct 12, 2026; now holds 326,993
- Rothblatt Martine A sold 1,857 shares at $551.92 (≈$1.02M) on Oct 12, 2026; now holds 325,136
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $783.30M (prior year $798.60M) (-1.9% vs Jun 30, 2025)
- Net income: $333.00M (prior year $309.50M) (+7.6% vs Jun 30, 2025)
- Diluted EPS: $7.27 (prior year $6.41) (+13.4% vs Jun 30, 2025)
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 13, 2026 · Form S-8 POS — S-8 POS filing
S-8 POS filing
Jul 13, 2026 · Form S-8 POS — S-8 POS filing
S-8 POS filing
Things to know before you trade UTHR
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 25, 2026, Oct 29, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.25% (largest 12.5%).
- Liquidity: about 950.22K shares (≈$506.58M) trade per day on average.
- 52-week position: $533.12 vs a range of $409.07–$609.35 (62% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Martine A Rothblatt sold 160 shares on Sep 29, 2026.
- Latest filings: 8-K Oct 14, 2026; 8-K Sep 8, 2026; 8-K Aug 5, 2026.
- Share count: 42.89M shares outstanding (Jul 29, 2026), -5.2% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
UTHR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 545.49 | 551.77 | 530.18 | 533.12 | 654.28K |
| Oct 15, 2026 | 545.24 | 551.83 | 538.07 | 541.51 | 545.40K |
| Oct 14, 2026 | 543.18 | 546.89 | 523.95 | 540.03 | 883.20K |
| Oct 13, 2026 | 551.59 | 553.99 | 542.23 | 543.40 | 537.70K |
| Oct 12, 2026 | 553.49 | 555.59 | 547.76 | 550.10 | 840.60K |
| Oct 9, 2026 | 528.92 | 551.15 | 528.92 | 549.16 | 577.90K |
| Oct 8, 2026 | 545.00 | 545.00 | 524.79 | 532.78 | 1.44M |
| Oct 7, 2026 | 542.41 | 558.30 | 541.90 | 545.00 | 1.01M |
| Oct 6, 2026 | 537.19 | 546.16 | 527.33 | 541.62 | 1.21M |
| Oct 5, 2026 | 540.41 | 547.98 | 535.53 | 536.40 | 833.70K |
| Oct 2, 2026 | 570.00 | 577.02 | 541.27 | 541.70 | 1.12M |
| Oct 1, 2026 | 557.53 | 585.79 | 556.76 | 571.38 | 1.69M |
| Sep 30, 2026 | 482.20 | 557.37 | 475.46 | 541.89 | 3.34M |
| Sep 29, 2026 | 485.54 | 487.62 | 471.34 | 481.47 | 439.90K |
| Sep 28, 2026 | 473.84 | 486.98 | 470.76 | 485.54 | 628.20K |
| Sep 25, 2026 | 474.04 | 479.97 | 470.40 | 475.45 | 472.40K |
| Sep 24, 2026 | 472.72 | 481.32 | 468.97 | 472.21 | 585.50K |
| Sep 23, 2026 | 498.82 | 500.05 | 487.73 | 489.42 | 433.40K |
| Sep 22, 2026 | 493.98 | 499.58 | 488.08 | 497.59 | 586.40K |
| Sep 21, 2026 | 497.70 | 497.70 | 491.26 | 493.10 | 1.19M |
About United Therapeutics
United Therapeutics (UTHR) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SILVER SPRING, MD. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1082554.
UTHR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Christopher Causey | Director | Jul 23, 2026 |
| Victor J Dzau | Director | Jul 23, 2026 |
| Richard Giltner | Director | Jul 23, 2026 |
| Ray Kurzweil | Director | Jul 23, 2026 |
| Jan Malcolm | Director | Jul 23, 2026 |
| Linda Maxwell | Director | Jul 23, 2026 |
| Nilda Mesa | Director | Sep 15, 2026 |
| Judy D. Olian | Director | Jul 23, 2026 |
| Christopher Patusky | Director | Jul 23, 2026 |
| Martine A Rothblatt | Chairperson & CEO | Sep 30, 2026 |
| Louis W Sullivan | Director | Jul 23, 2026 |
| Tommy G Thompson | Director | Jul 23, 2026 |
| Kevin Tracey | Director | Jul 23, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael Benkowitz | PRESIDENT AND COO | May 14, 2026 |
| James Edgemond | CFO AND TREASURER | Jun 23, 2026 |
| Paul A Mahon | EVP & GENERAL COUNSEL | Sep 18, 2026 |
| Martine A Rothblatt | Chairperson & CEO | Sep 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 29, 2026 | Martine A Rothblatt | Sale | 160 | $479.59 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 120 | $482.28 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 200 | $486.77 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 400 | $472.05 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 449 | $472.97 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 80 | $473.86 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 552 | $475.12 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 1,395 | $476.10 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 2,135 | $477.09 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 500 | $481.22 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 1,200 | $479.07 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 2,309 | $478.10 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 160 | $479.59 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 120 | $482.28 |
| Sep 29, 2026 | Martine A Rothblatt | Sale | 200 | $486.77 |
UTHR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $3.18B | $1.33B | 27.86 | $1.56B |
| Dec 31, 2024 | $2.88B | $1.20B | 24.64 | $1.33B |
| Dec 31, 2023 | $2.33B | $984.80M | 19.81 | $978.00M |
| Dec 31, 2022 | $1.94B | $727.30M | 15.00 | $802.50M |
| Dec 31, 2021 | $1.69B | $475.80M | 10.06 | $598.20M |
Latest balance sheet: total assets $7.22B, total liabilities $819.80M, cash $1.80B (as of Jun 30, 2026).
UTHR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $519.01 |
| May 6, 2026 | 8-K Item 2.02 (results) | $596.76 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $535.10 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $455.32 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $281.95 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $303.09 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $318.89 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $361.40 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Feb 21, 2024 | 8-K Item 2.02 (results) | — |
| Nov 1, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on UTHR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.